Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000921895-25-002083·Bio Green Med Solution, Inc.
Schedule 13D ownership disclosure
CYCLACEL PHARMACEUTICALS INC
Common Stock, $0.001 par value · CUSIP: 23254L801
Event date: 2025-07-30
- Filing-level shares
- 129,629.00
- Percent of class
- 8.18%
- Lazar David E.Reported CIK 0001932843
Shares: 129,629.00 · Class: 8.18%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-25-002083
- Form type
- SCHEDULE 13D/A
- Filer
- Bio Green Med Solution, Inc.
- CIK
- CIK 1130166
- Filed
- Aug 04, 2025
- Reporting period
- Jul 30, 2025
- Description
- Schedule 13D beneficial ownership